Agios Pharmaceuticals Free Cash Flow 2012-2024 | AGIO
Agios Pharmaceuticals free cash flow from 2012 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Agios Pharmaceuticals Annual Free Cash Flow | |
|---|---|
| 2023 | -295.74 |
| 2022 | -313.40 |
| 2021 | -413.06 |
| 2020 | -304.87 |
| 2019 | -382.65 |
| 2018 | -311.41 |
| 2017 | -289.86 |
| 2016 | 28.65 |
| 2015 | -97.11 |
| 2014 | -61.57 |
| 2013 | -57.69 |
| 2012 | -51.02 |
| 2011 | -17.13 |
| Agios Pharmaceuticals Quarterly Free Cash Flow | |
|---|---|
| 2024-06-30 | -172.72 |
| 2024-03-31 | -99.97 |
| 2023-12-31 | -295.74 |
| 2023-09-30 | -223.01 |
| 2023-06-30 | -162.18 |
| 2023-03-31 | -95.43 |
| 2022-12-31 | -313.40 |
| 2022-09-30 | -248.08 |
| 2022-06-30 | -176.69 |
| 2022-03-31 | -100.54 |
| 2021-12-31 | -413.06 |
| 2021-09-30 | -324.47 |
| 2021-06-30 | -239.30 |
| 2021-03-31 | -121.76 |
| 2020-12-31 | -304.87 |
| 2020-09-30 | -254.91 |
| 2020-06-30 | -181.50 |
| 2020-03-31 | -109.55 |
| 2019-12-31 | -382.65 |
| 2019-09-30 | -282.36 |
| 2019-06-30 | -194.73 |
| 2019-03-31 | -105.31 |
| 2018-12-31 | -311.41 |
| 2018-09-30 | -236.17 |
| 2018-06-30 | -169.19 |
| 2018-03-31 | -100.43 |
| 2017-12-31 | -289.86 |
| 2017-09-30 | -214.13 |
| 2017-06-30 | -134.39 |
| 2017-03-31 | -74.37 |
| 2016-12-31 | 28.65 |
| 2016-09-30 | 81.09 |
| 2016-06-30 | 133.55 |
| 2016-03-31 | -21.54 |
| 2015-12-31 | -97.11 |
| 2015-09-30 | -64.40 |
| 2015-06-30 | -36.28 |
| 2015-03-31 | -29.38 |
| 2014-12-31 | -61.57 |
| 2014-09-30 | -52.31 |
| 2014-06-30 | -28.21 |
| 2014-03-31 | -27.05 |
| 2013-12-31 | -57.69 |
| 2013-09-30 | -43.86 |
| 2013-06-30 | -28.78 |
| 2013-03-31 | -12.26 |
| 2012-12-31 | |
| 2012-09-30 | -39.37 |
| 2012-06-30 | -26.83 |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.556B | $0.027B |
| Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $203.272B | 26.25 |
| Stryker (SYK) | United States | $140.156B | 32.75 |
| Boston Scientific (BSX) | United States | $123.450B | 37.59 |
| Medtronic (MDT) | Ireland | $115.424B | 17.18 |
| EssilorLuxottica (ESLOY) | France | $105.988B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.352B | 34.60 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.218B | 0.00 |
| ResMed (RMD) | United States | $36.837B | 32.43 |
| Koninklijke Philips (PHG) | Netherlands | $28.913B | 21.97 |
| Terumo (TRUMY) | Japan | $27.831B | 39.31 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.412B | 13.48 |
| Baxter (BAX) | United States | $20.091B | 13.63 |
| Insulet (PODD) | United States | $16.158B | 67.98 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.705B | 0.00 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.972B | 29.73 |
| BellRing Brands (BRBR) | United States | $7.584B | 32.07 |
| Lantheus Holdings (LNTH) | United States | $7.223B | 17.34 |
| ICU Medical (ICUI) | United States | $4.254B | 40.60 |
| Haemonetics (HAE) | United States | $3.749B | 18.55 |
| Perrigo (PRGO) | Ireland | $3.702B | 11.70 |
| Prestige Consumer Healthcare (PBH) | United States | $3.613B | 18.00 |
| TG Therapeutics (TGTX) | United States | $3.590B | 38.02 |
| GN Store Nord (GNNDY) | Denmark | $3.560B | 21.44 |
| Neogen (NEOG) | United States | $3.357B | 35.23 |
| Envista Holdings (NVST) | United States | $3.210B | 17.13 |
| QuidelOrtho (QDEL) | United States | $3.012B | 18.98 |
| Green Thumb Industries (GTBIF) | United States | $2.190B | 36.75 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.172B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.981B | 52.80 |
| AdaptHealth (AHCO) | United States | $1.451B | 10.48 |
| Warby Parker (WRBY) | United States | $1.445B | 0.00 |
| InMode (INMD) | Israel | $1.407B | 8.96 |
| AtriCure (ATRC) | United States | $1.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.124B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.120B | 0.00 |
| Owens & Minor (OMI) | United States | $1.109B | 8.57 |
| Evolus (EOLS) | United States | $1.039B | 0.00 |
| PetIQ (PETQ) | United States | $0.916B | 23.23 |
| Phibro Animal Health (PAHC) | United States | $0.859B | 17.82 |
| National Vision Holdings (EYE) | United States | $0.816B | 25.95 |
| Cresco Labs (CRLBF) | United States | $0.810B | 0.00 |
| Surmodics (SRDX) | United States | $0.557B | 118.21 |
| Valneva SE (VALN) | France | $0.486B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.470B | 14.17 |
| ZimVie (ZIMV) | United States | $0.448B | 41.64 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Jin Medical (ZJYL) | China | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.378B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.341B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.318B | 8.19 |
| Biote (BTMD) | United States | $0.311B | 14.32 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.12 |
| Zynex (ZYXI) | United States | $0.250B | 43.83 |
| Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.229B | 15.22 |
| MacroGenics (MGNX) | United States | $0.226B | 0.00 |
| Omeros (OMER) | United States | $0.217B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.136B | 0.00 |
| Brainsway (BWAY) | Israel | $0.134B | 161.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Veru (VERU) | United States | $0.122B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.120B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.105B | 10.61 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 23.60 |
| InterCure (INCR) | Israel | $0.090B | 15.15 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Modular Medical (MODD) | United States | $0.071B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| Exagen (XGN) | United States | $0.052B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.050B | 3.25 |
| Apyx Medical (APYX) | United States | $0.043B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Bright Green (BGXX) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |